Efficacy of neo-adjuvant gemcitabine plus cisplatin (GC) in muscle-invasive urothelial cancer (UC)

被引：0
|
作者：
Dash, A. [1 ]
Pettus, J. A. [1 ]
Bochner, B. H. [1 ]
Dalbagni, G. [1 ]
Donat, S. M. [1 ]
Herr, H. W. [1 ]
Bajorin, D. F. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5077
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant Gemcitabine Plus Cisplatin for Muscle-invasive Bladder Cancer
    Kaneko, Gou
    Kikuchi, Eiji
    Matsumoto, Kazuhiro
    Obata, Jun
    Nakamura, So
    Miyajima, Akira
    Oya, Mototsugu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (07) : 908 - 914
  • [2] Neo-adjuvant chemotherapy for muscle-invasive bladder cancer: a look ahead
    Sawhney, R.
    Bourgeois, D.
    Chaudhary, U. B.
    ANNALS OF ONCOLOGY, 2006, 17 (09) : 1360 - 1369
  • [3] Comparison between neoadjuvant and adjuvant gemcitabine plus cisplatin chemotherapy for muscle-invasive bladder cancer
    Matsubara, Nobuaki
    Mukai, Hirofumi
    Naito, Yoichi
    Nezu, Masahiko
    Itoh, Kuniaki
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 (04) : 310 - 317
  • [4] Neoadjuvant Nivolumab Plus Gemcitabine/Cisplatin Chemotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder
    Kim, Hongsik
    Jeong, Byong Chang
    Hong, Joohyun
    Kwon, Ghee Young
    Kim, Chan Kyo
    Park, Won
    Pyo, Hongryull
    Song, Wan
    Sung, Hyun Hwan
    Hong, Jung Yong
    Park, Se Hoon
    CANCER RESEARCH AND TREATMENT, 2023, 55 (02): : 636 - 642
  • [5] A study of split-dose cisplatin-based neo-adjuvant chemotherapy in muscle-invasive bladder cancer
    Hussain, S. A.
    Palmer, D. H.
    Lloyd, B.
    Collins, S. I.
    Barton, D.
    Ansari, J.
    James, N. D.
    ONCOLOGY LETTERS, 2012, 3 (04) : 855 - 859
  • [6] A Role for Neoadjuvant Gemcitabine Plus Cisplatin in Muscle-Invasive Urothelial Carcinoma of the Bladder A Retrospective Experience
    Dash, Atreya
    Pettus, Joseph A.
    Herr, Harry W.
    Bochner, Bernard H.
    Dalbagni, Guido
    Donat, S. Machele
    Russo, Paul
    Boyle, Mary G.
    Milowsky, Matthew I.
    Bajorin, Dean F.
    CANCER, 2008, 113 (09) : 2471 - 2477
  • [7] The efficacy and safety of tislelizumab combined with gemcitabine plus cisplatin in the treatment of postoperative patients with muscle-invasive upper tract urothelial carcinoma
    Zhang, Jingwen
    Yang, Meng
    Wei, Dongqun
    Zhang, Deru
    Chen, Zeyu
    Zhu, Haitao
    BMC CANCER, 2024, 24 (01)
  • [8] The efficacy and safety of tislelizumab combined with gemcitabine plus cisplatin in the treatment of postoperative patients with muscle-invasive upper tract urothelial carcinoma
    Jingwen Zhang
    Meng Yang
    Dongqun Wei
    Deru Zhang
    Zeyu Chen
    Haitao Zhu
    BMC Cancer, 24
  • [9] Feasibility of gemcitabine plus cisplatin as neo-adjuvant in cholangiocarcinoma patients prior to liver transplantation
    Esmail, A.
    Xu, J.
    Umoru, G.
    Al-Rawi, H.
    Saharia, A.
    Abdelrahim, M.
    ANNALS OF ONCOLOGY, 2022, 33 : S310 - S310
  • [10] Gemcitabine plus Cisplatin versus non-gemcitabine and Cisplatin as neo-adjuvant for cholangiocarcinoma patients prior to liver transplantation
    Abdelrahim, M.
    Esmail, A.
    Xu, J.
    Saharia, A.
    McMillan, R.
    Kodali, S.
    Umoru, G.
    Ghobrial, R. M.
    TRANSPLANTATION, 2022, 106 (8S) : 158 - 158
12345